Safety of HRX215 in Patients After Minor and Major Liver Resection

NCT06638502 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Resection
Colorectal Carcinoma Liver Metastases

Interventions

DRUG: HRX215 capsules
DRUG: Placebo capsules

Sponsor

HepaRegeniX GmbH